NO20024623L - Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform - Google Patents
Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallformInfo
- Publication number
- NO20024623L NO20024623L NO20024623A NO20024623A NO20024623L NO 20024623 L NO20024623 L NO 20024623L NO 20024623 A NO20024623 A NO 20024623A NO 20024623 A NO20024623 A NO 20024623A NO 20024623 L NO20024623 L NO 20024623L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- crystal form
- novel process
- new crystal
- imidazopyridine derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000092565 | 2000-03-30 | ||
| PCT/JP2001/002620 WO2001074821A1 (fr) | 2000-03-30 | 2001-03-29 | Nouveau procede de production de derive d'imidazopyridine fondu et nouvelle forme cristalline |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20024623D0 NO20024623D0 (no) | 2002-09-26 |
| NO20024623L true NO20024623L (no) | 2002-11-08 |
Family
ID=18607880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024623A NO20024623L (no) | 2000-03-30 | 2002-09-26 | Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7049437B2 (fr) |
| EP (1) | EP1270578A4 (fr) |
| JP (1) | JP3481930B2 (fr) |
| KR (1) | KR20020082898A (fr) |
| CN (1) | CN1203073C (fr) |
| AU (1) | AU2001244613A1 (fr) |
| BR (1) | BR0109643A (fr) |
| CA (1) | CA2403131A1 (fr) |
| CZ (1) | CZ20023276A3 (fr) |
| HK (1) | HK1054387A1 (fr) |
| HU (1) | HUP0300580A3 (fr) |
| IL (1) | IL151877A0 (fr) |
| MX (1) | MXPA02009460A (fr) |
| NO (1) | NO20024623L (fr) |
| PL (1) | PL357672A1 (fr) |
| WO (1) | WO2001074821A1 (fr) |
| ZA (1) | ZA200207295B (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003008421A1 (fr) * | 2001-07-16 | 2003-01-30 | Shionogi & Co., Ltd. | Procede de preparation de derives amidine |
| JPWO2004078173A1 (ja) * | 2003-02-05 | 2006-06-08 | 塩野義製薬株式会社 | 溶出性の改善された錠剤 |
| JP2007502293A (ja) | 2003-08-12 | 2007-02-08 | スリーエム イノベイティブ プロパティズ カンパニー | ヒドロキシルアミン置換イミダゾ含有化合物 |
| RU2006105101A (ru) | 2003-08-27 | 2007-10-10 | 3М Инновейтив Пропертиз Компани (US) | Арилокси и арилалкиленокси замещенные имидазохинолины |
| CA2537763A1 (fr) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Traitement pour le lymphome a cellules b cd5<sp>+</sp> |
| AU2004278014B2 (en) | 2003-10-03 | 2011-04-28 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| JP2007511527A (ja) | 2003-11-14 | 2007-05-10 | スリーエム イノベイティブ プロパティズ カンパニー | オキシム置換イミダゾ環化合物 |
| US8598192B2 (en) * | 2003-11-14 | 2013-12-03 | 3M Innovative Properties Company | Hydroxylamine substituted imidazoquinolines |
| WO2005051317A2 (fr) | 2003-11-25 | 2005-06-09 | 3M Innovative Properties Company | Systèmes cycliques d'imidazo substitués et procédés |
| WO2005066170A1 (fr) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Imidazoquinolines a substitution arylalcenyle et arylalkynyle |
| CA2551399A1 (fr) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle |
| US8697873B2 (en) | 2004-03-24 | 2014-04-15 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| US20080058281A1 (en) * | 2004-03-30 | 2008-03-06 | Yates Paula R | Skin Lightening Compositions Comprising Vitamines and Flavonoids |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| US7915281B2 (en) | 2004-06-18 | 2011-03-29 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
| US20070259881A1 (en) * | 2004-06-18 | 2007-11-08 | Dellaria Joseph F Jr | Substituted Imidazo Ring Systems and Methods |
| JP5313502B2 (ja) | 2004-12-30 | 2013-10-09 | スリーエム イノベイティブ プロパティズ カンパニー | 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| JP5543068B2 (ja) | 2004-12-30 | 2014-07-09 | スリーエム イノベイティブ プロパティズ カンパニー | キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| JP2008530022A (ja) | 2005-02-04 | 2008-08-07 | コーリー ファーマシューティカル グループ，インコーポレイテッド | 免疫反応調節物質を含む水性ゲル処方物 |
| AU2006213746A1 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods |
| AU2006232375A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| WO2006107853A2 (fr) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines et analogues associes |
| EP1937683A4 (fr) * | 2005-09-23 | 2010-08-25 | Coley Pharm Group Inc | Procede de preparation de 1h-imidazoý4,5-c¨pyridines et d'analogues de ceux-ci |
| WO2008008432A2 (fr) | 2006-07-12 | 2008-01-17 | Coley Pharmaceutical Group, Inc. | Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378848A (en) * | 1992-02-12 | 1995-01-03 | Shionogi & Co., Ltd. | Condensed imidazopyridine derivatives |
| IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
-
2001
- 2001-03-29 CA CA002403131A patent/CA2403131A1/fr not_active Abandoned
- 2001-03-29 EP EP01917588A patent/EP1270578A4/fr not_active Withdrawn
- 2001-03-29 KR KR1020027012412A patent/KR20020082898A/ko not_active Application Discontinuation
- 2001-03-29 WO PCT/JP2001/002620 patent/WO2001074821A1/fr not_active Application Discontinuation
- 2001-03-29 CN CNB018073417A patent/CN1203073C/zh not_active Expired - Fee Related
- 2001-03-29 BR BR0109643-5A patent/BR0109643A/pt not_active IP Right Cessation
- 2001-03-29 CZ CZ20023276A patent/CZ20023276A3/cs unknown
- 2001-03-29 HU HU0300580A patent/HUP0300580A3/hu unknown
- 2001-03-29 JP JP2001572511A patent/JP3481930B2/ja not_active Expired - Fee Related
- 2001-03-29 AU AU2001244613A patent/AU2001244613A1/en not_active Abandoned
- 2001-03-29 IL IL15187701A patent/IL151877A0/xx unknown
- 2001-03-29 PL PL01357672A patent/PL357672A1/xx not_active Application Discontinuation
- 2001-03-29 US US10/239,785 patent/US7049437B2/en not_active Expired - Fee Related
- 2001-03-29 MX MXPA02009460A patent/MXPA02009460A/es not_active Application Discontinuation
-
2002
- 2002-09-11 ZA ZA200207295A patent/ZA200207295B/en unknown
- 2002-09-26 NO NO20024623A patent/NO20024623L/no not_active Application Discontinuation
-
2003
- 2003-09-16 HK HK03106654.1A patent/HK1054387A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1054387A1 (zh) | 2003-11-28 |
| HUP0300580A3 (en) | 2006-06-28 |
| BR0109643A (pt) | 2003-04-22 |
| AU2001244613A1 (en) | 2001-10-15 |
| US20030088102A1 (en) | 2003-05-08 |
| KR20020082898A (ko) | 2002-10-31 |
| CA2403131A1 (fr) | 2001-10-11 |
| MXPA02009460A (es) | 2003-02-12 |
| US7049437B2 (en) | 2006-05-23 |
| WO2001074821A1 (fr) | 2001-10-11 |
| EP1270578A4 (fr) | 2004-11-03 |
| NO20024623D0 (no) | 2002-09-26 |
| PL357672A1 (en) | 2004-07-26 |
| EP1270578A1 (fr) | 2003-01-02 |
| CZ20023276A3 (cs) | 2003-02-12 |
| CN1203073C (zh) | 2005-05-25 |
| JP3481930B2 (ja) | 2003-12-22 |
| ZA200207295B (en) | 2003-09-11 |
| IL151877A0 (en) | 2003-04-10 |
| HUP0300580A2 (hu) | 2003-07-28 |
| CN1419557A (zh) | 2003-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024623D0 (no) | Ny fremgangsmåte for fremstilling av kondensert imidazopyridinderivat og ny krystallform | |
| NO20030844D0 (no) | Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav | |
| NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
| NO20031694L (no) | Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament | |
| NO20022176D0 (no) | Absorberende gjenstand og fremgangsmåte for fremstilling av denne | |
| NO20032518L (no) | Fremgangsmåte for fremstilling av amlodipinmaleat | |
| CY2009001I2 (el) | Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης | |
| NO20015542D0 (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
| NO20013942D0 (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20023950L (no) | Fremgangsmåte for fremstilling av en titanholdig zeolitt | |
| NO20024321D0 (no) | Fremgangsmåte for fremstilling av krystallinsk form I av kabergolin | |
| NO20021124D0 (no) | Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor | |
| NO20031413L (no) | Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt | |
| NO20003555L (no) | Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer | |
| NO20025069L (no) | Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme | |
| NO20025423L (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20023973D0 (no) | Fremgangsmåte for fremstilling av en titanholdig zeolitt | |
| NO20021118D0 (no) | Fremgangsmåte for fremstilling av citalopram | |
| DK1339723T3 (da) | Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner | |
| NO20030515D0 (no) | Fremgangsmåte for fremstilling av dinapsolin | |
| NO20023577L (no) | Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider | |
| NO20030587D0 (no) | Fremgangsmåte til fremstilling av diskodermolid og analoger derav | |
| NO20032297D0 (no) | Fremgangsmåte for fremstilling av distamycinderivater | |
| NO20023702L (no) | Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder | |
| NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |